A new report in the Journal of the American Medical Association adds to the mounting evidence that genetic variations impact the efficacy of clopidogrel (Plavix®), a drug used to prevent blood clots in people who have had a heart attack or stroke and also those with peripheral artery disease and unstable angina.
Previous research has shown [...]

Tags: angina, clopidogrel, clotting, heart attack, JAMA, peripheral artery disease, Plavix, stroke